SK

Shobhna Khare

Active Director Director DIN 07790433
DIN 07790433 First appointment May 2017 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since May 2017
Shareholding value Locked Premium profile

About Shobhna Khare

Shobhna Khare has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Experon Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07790433
Primary Designation Director
First Appointment 01 May 2017
Oldest Company Age 9 yrs

Current companies

Company Designation Appointment Founded Status
Director 01 May 2017 2017 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Experon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shobhna Khare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shobhna Khare

Shobhna Khare has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Experon Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Shobhna Khare is associated with 1 company as Director.

Shobhna Khare has expertise in General Business.

Shobhna Khare has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available